Literature DB >> 27402146

A prognostically relevant miRNA signature for epithelial ovarian cancer.

Daniel W Cramer1, Kevin M Elias2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27402146     DOI: 10.1016/S1470-2045(16)30149-8

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  8 in total

1.  microRNA-324-3p suppresses the aggressive ovarian cancer by targeting WNK2/RAS pathway.

Authors:  Fengjie Li; Zhen Liang; Yongqin Jia; Panyang Zhang; Kaijian Ling; Yanzhou Wang; Zhiqing Liang
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

2.  MicroRNA-370 suppresses the progression and proliferation of human astrocytoma and glioblastoma by negatively regulating β-catenin and causing activation of FOXO3a.

Authors:  Ming Lu; Yong Wang; Shizhen Zhou; Jun Xu; Jing Li; Rongjie Tao; Yufang Zhu
Journal:  Exp Ther Med       Date:  2017-11-13       Impact factor: 2.447

3.  Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer.

Authors:  Kevin M Elias; Wojciech Fendler; Konrad Stawiski; Stephen J Fiascone; Allison F Vitonis; Ross S Berkowitz; Gyorgy Frendl; Panagiotis Konstantinopoulos; Christopher P Crum; Magdalena Kedzierska; Daniel W Cramer; Dipanjan Chowdhury
Journal:  Elife       Date:  2017-10-31       Impact factor: 8.140

4.  Common miRNAs, candidate genes and their interaction network across four subtypes of epithelial ovarian cancer.

Authors:  Rinki Singh; Anup Som
Journal:  Bioinformation       Date:  2021-08-31

5.  Molecular mechanism of CAIF inhibiting myocardial infarction by sponging miR‑488 and regulating AVEN expression.

Authors:  Xiaoling Li; Runqi Chen; Lina Wang; Zengxue Lu; Yangjie Li; Dun Tang
Journal:  Mol Med Rep       Date:  2022-07-07       Impact factor: 3.423

6.  The Circulating Micro-RNAs (-122, -34a and -99a) as Predictive Biomarkers for Non-Alcoholic Fatty Liver Diseases.

Authors:  Olfat M Hendy; Hatem Rabie; Amr El Fouly; Mohamed Abdel-Samiee; Nashwa Abdelmotelb; Amr Aly Elshormilisy; Mahmoud Allam; Samia Taher Ali; Nessren Mohamed Bahaa El-Deen; Shimaa Abdelsattar; Somia Mokabel Mohamed
Journal:  Diabetes Metab Syndr Obes       Date:  2019-12-19       Impact factor: 3.168

7.  Expression profiles analysis reveals an integrated miRNA-lncRNA signature to predict survival in ovarian cancer patients with wild-type BRCA1/2.

Authors:  Liyuan Guo; Yan Peng; Yuanyuan Meng; Yunduo Liu; Shangshang Yang; Hong Jin; Qi Li
Journal:  Oncotarget       Date:  2017-07-26

8.  Prognostic Evidence of the miRNA-Based Ovarian Cancer Signature MiROvaR in Independent Datasets.

Authors:  Loris De Cecco; Marina Bagnoli; Paolo Chiodini; Sandro Pignata; Delia Mezzanzanica
Journal:  Cancers (Basel)       Date:  2021-03-27       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.